Skip to main content
Medtronic plc logo

Medtronic plc — Investor Relations & Filings

Ticker · MDT ISIN · US58446C1036 LEI · D56MRZY2INAN94ZONZ37 US Manufacturing
Open in API
Filings indexed 1,143 across all filing types
Latest filing 2018-01-10 Director's Dealing
Country US United States of America
Listing US MDT

About Medtronic plc

https://www.medtronic.com/

Medtronic plc is a global healthcare technology company that develops, manufactures, and sells device-based medical therapies and solutions. The company's portfolio addresses more than 70 health conditions, primarily organized into four key areas: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. Its products range from pacemakers and neurovascular care devices to insulin pumps and systems for robotic-assisted surgery. Medtronic's technologies are designed to be used by healthcare systems, physicians, clinicians, and patients to alleviate pain, restore health, and extend life.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2018-01-10 English
PRIMARY DOCUMENT
Director's Dealing
2018-01-08 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the announcement of a multi-year global Enterprise Excellence Program including expected costs, savings, and restructuring plans. There are no detailed financial statements or comprehensive financial performance data typical of annual or quarterly reports. The document is not a transcript, proxy, or governance report. It is a regulatory announcement of a significant corporate program and related costs, fitting the profile of a Regulatory Filing (RNS) rather than a full financial report or other specific category. The document length (6695 characters) and content support this classification.
2018-01-08 English
PRIMARY DOCUMENT
Director's Dealing
2017-12-29 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 18, 2017, reporting changes in the company's executive management, specifically the resignation of an Executive Vice President and the appointment of new executives. The key section is Item 5.02, which deals with departure and appointment of directors or officers. The document includes a press release as an exhibit announcing these leadership changes. There are no financial statements or detailed financial data present, and the document is focused on management changes. Therefore, this filing fits the category of Board/Management Information (MANG). The document length is 4184 characters, which is consistent with a typical 8-K management change filing. Confidence is high due to clear identification of management changes and the nature of the filing as a Form 8-K reporting such changes.
2017-12-19 English
PRIMARY DOCUMENT
Director's Dealing
2017-12-18 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.